Kyushu University Open Innovation Platform and CellTech Accelerator Announce Memorandum of Understanding to Foster Cross-Border Innovation
Taipei, Taiwan – March 27th, 2025 – Kyushu University Open Innovation Platform (OIP) and CellTech Accelerator today announced the signing of a Memorandum of Understanding (MOU), establishing a strategic partnership aimed at accelerating the development and commercialization of biotech innovations between Japan and Taiwan.
This collaboration signifies a mutual commitment to facilitating the exchange of knowledge, resources, and expertise to support the growth of startups and foster cross-border collaborations.
Kyushu University OIP, a key initiative of Kyushu University, is dedicated to promoting open innovation by bridging the gap between academic research and industry. The platform provides a comprehensive framework for fostering partnerships and driving technological advancements.
CellTech Accelerator, a leading organization specializing in the acceleration of biotech startups, offers a robust ecosystem of support, including mentorship, funding opportunities, and market access.
The MOU outlines the following key objectives:
- Joint Program Development: To create collaborative programs designed to support the development and growth of startups in the biotech sector.
- Cross-Border Collaboration Facilitation: To establish mechanisms for facilitating collaborations between startups and research institutions in Japan and Taiwan.
- Knowledge and Resource Sharing: To promote the exchange of expertise, resources, and best practices to enhance the innovation ecosystem.
- Market Access Expansion: To facilitate the expansion of market access for innovative technologies developed by startups from both regions.
“We are honored to partner with Kyushu University OIP to accelerate the growth of biotech startups,” said James Tsai, the CEO of CellTech Accelerator. “This collaboration will enable us to leverage our respective strengths and create a powerful platform for cross-border innovation.”
This MOU marks the beginning of a long-term partnership aimed at fostering a dynamic and collaborative environment for biotech innovation.
About Kyushu University Open Innovation Platform (OIP):
Kyushu University Open Innovation Platform (OIP) is a strategic initiative designed to accelerate the creation of new industries and drive regional economic development through the promotion of open innovation. OIP acts as a bridge between the university’s world-class research capabilities and the needs of industry, facilitating collaborative projects, technology transfer, and the incubation of startups. By fostering partnerships with corporations, venture capitalists, and other stakeholders, OIP aims to create a vibrant ecosystem that supports the commercialization of cutting-edge technologies and the development of innovative businesses. It provides comprehensive support, including access to research facilities, expert mentorship, and networking opportunities, empowering entrepreneurs and researchers to bring their ideas to market.
For more information, please visit: https://ku-oip.co.jp/
About CellTech Accelerator:
CellTech Accelerator is the first startup accelerator in Asia solely focused on advancing the cell and gene therapy industry. It supports entrepreneurs in translating cell therapy technologies into practical applications by providing financial support, consulting, and commercialization training services. The company has established an entrepreneurial ecosystem and collaborates with investors and industry partners to drive technology commercialization. Additionally, it offers a comprehensive support system that addresses all aspects of growth for cell and gene therapy ventures.
For more information, please visit https://genecelltech.com/